Figure 1. Asparagine-Linked Oligosaccharide Biosynthesis
The depicted oligosaccharide precursor is transferred from lipid to asparagines on nascent peptides in the endoplasmic reticulum prior to glucosidase and ␣1-2 mannosidase trimming. In the medial Golgi, Mgat1-encoded GlcNAc-TI initiates hybrid N-glycan synthesis. Conversion to complex N-glycans requires ␣-mannosidase-II to generate the processed hybrid N-glycan that is also the substrate of GlcNAc-TII. Anomeric linkage types are denoted. Closed triangles represent glucose; open circles, mannose; closed squares, N-acetylglucosamine. Addition of fucose (open triangle) may occur earlier than indicated. Multi-antennary complex N-glycans result from other branching reactions (arrows).
Results
GlcNAc 1 Man 3 GlcNAc-PA, but was absent from extracts derived from ␣MII ⌬ /␣M-II ⌬ mice or extracts treated with swainsonine ( Figures 3A and 3B ; data not shown). Addi-
␣M-II Gene Inactivation in Embryonic Stem Cells and Mice
tionally, an antibody specific for ␣M-II failed to immunoprecipitate ␣M-II activity from total cell extracts derived ␣M-II is a type II transmembrane protein of 1150 amino acids encoded by a single gene locus in studied vertefrom ␣MII ⌬ /␣M-II ⌬ samples (data not shown). These experiments demonstrated that the exon deletion probrates Moremen et al., 1994) . A mouse genomic clone that contained an exon duced in the ␣M-II gene (␣M-II ⌬ ) results in a complete loss of enzyme activity and is thus a genetic null allele. representing a portion of the lumenal "stem" domain of ␣M-II was isolated. As sequence analysis indicated that excision of this exon would create a translational frameshift mutation, a gene targeting construct was proMice Lacking a Functional ␣M-II Allele Exhibit Splenomegaly Associated duced that would permit excision of this exon and removal of the marker genes by Cre recombinase (Figure with Dyserythropoietic Anemia Mice lacking a functional ␣M-II allele did not display 2A; reviewed in Marth, 1996) . G418 resistant embryonic stem cell clones were analyzed for homologous recomnoticable neurologic or behavioral symptoms and bred normally with either wild-type or homozygous-null mates. bination events, producing a modified ␣M-II locus bearing three loxP sites as required to produce systemic Histologic findings of the liver, brain, kidney, lymph nodes, heart, lung, and pancreas were unremarkable. (⌬) and conditional (F) mutations (Figures 2B and 2C) . Chimeric mice generated from ES clones 34-107 and Leukocyte development, morphology, circulation, and colonization of secondary lymphoid organs also ap-31-107 were bred to C57BL/6 mates to produce mice heterozygous for ␣M-II ⌬ or ␣M-II F alleles, respectively. peared normal in ␣M-II-deficient mice (data not shown). However, analyses of peripheral blood indicated high Offspring homozygous for either allele were obtained at normal frequencies, and those bearing ␣M-II ⌬ alleles levels of reticulocytes and significant variations in erythrocyte cell size (anisocytosis) ( Figure 4A ). ␣M-II-deficient were further analyzed.
mice of all ages invariably exhibited a marked splenomegaly ( Figure 4B ). Additionally, detailed hematologic Mice Homozygous for the ␣M-II ⌬ Allele Lack ␣M-II Enzyme Activity analyses revealed a mild-to-moderate anemia, accompanied by a marked anisocytosis, reduced osmotic fra-␣M-II activity can be specifically determined using the fluorescent substrate GlcNAc1Man5GlcNAc-pyridylamgility, indicating a likely increase in the surface area to volume ratio, reticulocytosis involving up to 30% of ine (-PA). Release of mannose alters the chromatographic mobility of this molecule in a defined manner.
circulating red blood cells, and increased levels of the i-antigen ( Figures 4C-4G ). The ␣M-II-null bone marrow ␣M-II has been immunolocalized to the early Golgi apparatus in most cell types (Moremen et al., 1994) , and Golgi exhibited normal cellularity but an increase in erythroblasts ( Figure 4H ). Anisocytosis, reduced osmotic fragilfractions from genotyped mouse tissues were examined for ␣M-II activity by a 2 to 24 hr incubation with substrate ity, increased i-antigen levels, and erythroblast hyperplasia were observed in ␣M-II-null mice of all ages, in the presence or absence of swainsonine. ␣M-II activity was present in wild-type samples with the generation whereas the severity of the anemia and reticulocytosis increased with age. of the cleaved products GlcNAc 1 Man 4 GlcNAc-PA and 1992). This binding requires the action of GlcNAc-TII, which cannot occur without ␣M-II (Figure 1 ). In wildtype erythrocytes, at least six glycoproteins bearing complex N-linked oligosaccharides were visualized by E-PHA binding ( Figure 5A , right panel). This binding was absent from mutant samples, indicating that ␣M-II deficiency abrogates the production of complex N-glycans in erythrocytes. Mouse erythrocyte glycoproteins bearing complex N-linked oligosaccharides appeared upon close inspection to be distinct from those observed by Coomassie blue.
Erythroid Cells from ␣M-II-Null Mice Are Uniquely Deficient in Complex N-Glycans
Unexpectedly, analyses of various hematopoietic cells with E-PHA-biotin revealed that only erythocytes were deficient in complex N-glycans ( Figure 5B ). Thymocytes, myeloid cells, and mature lymphocytes displayed essentially normal levels of E-PHA binding, while erythroblast cell surfaces in the bone marrow were variably deficient. O-glycosylation appeared unaffected, as expected ( Figure 5C ); however, E-PHA histochemistry of the liver, kidney, spleen, pancreas, epidermis, and brain also indicated a normal level of cell surface complex N-glycans on ␣M-II-null cells (data not shown). Surprisingly, congenital loss of ␣M-II function appeared to ablate complex N-glycan production specifically in the erythroid lineage. This implied that an undisclosed alternate biosynthetic pathway was operating in other cell types. The nature of this alternate pathway was investigated by analyzing N-linked oligosaccharide biosynthesis and structural diversity in ␣M-II-deficient cells that retained E-PHA binding. normally added by Dol-P-Man (Stoll et al., 1982 ConA affinity chromatography is useful in determining cytes by SDS-PAGE and Coomassie blue staining, indicating that no changes occurred in the expression of the proportion of tetra-, tri-and biantennary complex, hybrid, and high mannose N-linked oligosaccharides the major membrane constituents ( Figure 5A , left panel). Glycoproteins bearing complex N-linked oligosaccha- (Baenziger and Fiete, 1979; Narasimhan et al., 1979) . flowthrough and in response to 10 mM ␣-methyl glucoenzyme was predicted to be specific for Man 5 GlcNAc 2 -Asn, generating Man 3 GlcNAc 2 -Asn, which is also a subside, as characteristic of complex forms. These were, however, distinctly underrepresented in ␣M-II-deficient strate for GlcNAc-TI from in vitro studies (Schachter, 1986 (Schachter, , 1991 . We therefore tested Golgi and microsomal extracts ( Figure 6B , peaks a, b, e, and f; data not shown). The proportion of high mannose N-glycans was unalfractions of various cell types for the presence of this ␣M activity. tered, and hybrid N-glycans were significantly increased as expected (Figure 6B, peaks c, d, g, and h ).
An ␣M activity toward Man5GlcNAc-PA was found in all mouse cell and tissue types tested, including splenoTo resolve further the N-linked oligosaccharide species separated by ConA-Sepharose chromatography, cytes, liver, kidney, and primary fibroblasts. This enzyme activity (termed ␣M-III) was optimal at pH 6.0-6.5 and, fractions were desialylated and analyzed by HPLC (Figure 6C ). Among those that eluted with 10 mM ␣-methylin the presence of Co 2ϩ , generated Man 4 GlcNAc-PA, Man 3 GlcNAc-PA, and even Man 2 GlcNAc-PA and Man 1-mannosidase, the abundance in peak 7 was greatly elevated with ␣M-II deficiency. Exoglycosidase studies of GlcNAc-PA at later time points ( Figure 7 and data not shown). No change in ␣M-III activity was observed peak 7 confirmed that this was a hybrid-type N-linked oligosaccharide species ( Figure 6C legend; Experimenamong ␣M-II-deficient cells. ␣M-III activity in the mouse appeared identical to an ␣M activity previously discovtal Procedures). Similar analyses of putative complex N-linked oligosaccharides previously eluted with 10 mM ered in the rat liver (Bonay and Hughes, 1991; Bonay et al., 1992) and was also greatly enriched in Golgi and ␣-methyl-glucoside ( Figure 6C , panels b and f, peak 2) revealed the standard biantennary complex oligosacmicrosomal preparations. A revision to the N-glycan biosynthetic pathway was therefore indicated, in which charide NA2 (Experimental Procedures). The biantennary complex N-linked oligosaccharide in HPLC peak 2 complex N-linked oligosaccharides are produced by two mutually exclusive routes ( Figure 8 ). was also confirmed by sequential exoglycosidase digestion to harbor the trimannosyl core ( Figure 6D , left panels). Complex N-linked oligosaccharides bearing the Discussion trimannosyl core were similarly revealed among ␣M-IIdeficient primary fibroblasts ( Figure 6D , right panels).
Alpha-Mannosidase Function in Complex These studies indicated that loss of ␣M-II activity did N-Glycan Biosynthesis not alter levels of high mannose N-glycans but resulted Our findings are consistent with ␣M-II acting specifically in a 3-fold increase in the abundance of hybrid N-glyto process the GlcNAc 1 Man 5 GlcNAc 2 -Asn hybrid during cans. Surprisingly, complex N-glycans were present in N-glycan biosynthesis. In the absence of ␣M-II, this hy-␣M-II-deficient cells at approximately 50% the level brid N-glycan is modified by Golgi ␤1-4 galactosyltransfound in wild-type cells and at apparently normal levels ferase prior to a 3-fold accumulation observed in splenoon the cell surface (Table 1; Figure 5B ). cytes and primary fibroblasts. Unexpectedly, complex N-glycans were found at approximately 50% of normal total cellular levels among ␣M-II-deficient splenocytes An Alternate Pathway to Complex N-Glycan Production and fibroblasts. The initial rate of conversion to complex N-glycans was found to be unchanged, and little or no The synthesis of complex N-glycans as determined above in ␣M-II-deficient cells was not compatible with complex N-glycan deficiency could be detected on the cell surface. ␣M-II-null cells generated complex N-linked the previously defined biosynthetic pathway. To explain these results, it was necessary to invoke the presence oligosaccharides bearing the trimannosyl core originating from an unaltered dolichol oligosaccharide precurof a distinct ␣M that functions early in N-glycan biosynthesis. Moreover, given the well-defined substrate specsor. These observations indicated the presence of a distinct ␣M activity functioning in an alternate pathway ificities of GlcNAc-TI and GlcNAc-TII, this distinct ␣M Erythrocytes of either genotype failed to agglutinate with a 1/120 dilution of anti-I antisera; however, anti-i antisera agglutinated ␣M-II-null erythrocytes at a 1/3840 dilution as compared with a 1/480 dilution required for wild-type erythrocytes. Agglutination response to anti-i antisera was defined as the maximum-fold reduction in antibody titer that continued to produce erythrocyte agglutination (n ϭ 3). in complex N-glycan biosynthesis. They may also indito complex N-glycan production hence includes a relatively swainsonine-resistant ␣M-III activity, functioning cate a low turnover rate for complex N-glycans at the cell surface, variable transport rates to the plasma memindependently and exclusive of ␣M-II (Figure 8 ). This revised pathway is also consistent with the lack of hybrid brane, and recycling mechanisms from the membrane allowing further oligosaccharide maturation. and complex N-glycans with GlcNAc-TI deficiency (Ioffe and Stanley, 1994; Metzler et al., 1994) . The previous An ␣M activity acting on Man 5 GlcNAc-PA and generating Man 3 GlcNAc-PA (termed ␣M-III) was found among unavailability of cells bearing ␣M-II-null alleles in combination with the cation dependence of ␣M-III activity in all mouse tissues surveyed and at levels comparable to wild-type and ␣M-II-null cells. ␣M-III activity in the vitro may explain why the alternate pathway was not revealed in earlier studies. mouse did not act on hybrid structures, including GlcNAcMan 5 GlcNAc-PA in the presence of Co 2ϩ , and exhibited a reduced sensitivity to inhibition by swainsonine when compared with ␣M-II (data not shown). ReDyserythropoiesis in Murine ␣M-II Deficiency and Relevance to Human CDA type II garding swainsonine inhibition of N-glycan biosynthesis, such studies have often reported finding various Erythroid cells are uniquely susceptible to alterations in N-linked oligosaccharide biosynthesis evoked by ␣M-II levels of complex N-glycans remaining. Our analyses of ␣M-II-deficient mice suggest that swainsonine-induced deficiency. This susceptibility arises from the apparent absence of an alternate pathway in complex N-glycan locoism with behavioral abnormalities, male sterility, and cellular vacuolation is not a result of ␣M-II inhibition.
production. Loss of complex N-linked oligosaccharides and other membrane-bound constituents can lead to Instead, swainsonine likely induces these effects by inhibition of the lysosomal ␣-mannosidase and perhaps defects involving ion transport, glycoprotein clustering, membrane fluidity, and cytoskeletal stability (Fukuda, other ␣M enzymes, depending upon the plasma levels of swainsonine attained in vivo. The alternate pathway 1993; Palek, 1995; Peters et al., 1996) . An increase in exposed mannose residues at the cell surface in ␣M-IIbases are yet unresolved (Beutler, 1995) . ␣M-II-deficient mice exhibit significant phenotypic similarities with hudeficient mice may also target erythrocytes for interaction with the mannose-receptor and macrophage enman CDA type II. Splenomegaly with increased marrow erythroblasts are common to both human and mouse gulfment within the spleen. In comparison with human erythrocyte glycoproteins known to contain complex syndromes, as are the variable severity of anemia, anisocytosis, and increased i-antigen levels. In CDA type II, N-linked oligosaccharides, mouse versions appear distinct and do not produce complex N-linked oligosacchathe increase in i-antigen levels occurs on glycolipids. In analyses of erythrocyte glycolipid structures from ␣M-rides on band 3. However, human and mouse glycophorin A may normally contain high levels of sialic acid on II-null mice, we observed a similar increase in those containing the endo-␤-galactosidase sensitive i-antigen complex N-linked oligosaccharide termini (Angel et al., 1991) . Absence of complex N-linked oligosaccharides polylactosamine (data not shown). Since normal mouse erythrocytes display low levels of I-and i-antigens, may yield glycoproteins that are hypomorphic, dysfunctional, or destabilized and perhaps absent from the i-antigen induction may reflect a decreased erythroid maturation time common to the dyserythropoietic marmembrane. Multiple targets as potential phenotypic effectors commonly arise in studies of enzyme deficienrow (Beutler, 1995) . Glycosylation abnormalities in CDA type II otherwise occur in a manner that would be excies. Likewise, identification of altered glycoproteins in ␣M-II-deficient erythrocytes will be relevant in defining pected for aberrant N-glycan production with deficiency of ␣M-II, GlcNAc-TII, or a galactosyltransferase (Fukuda the inductive events that precipitate dyserythropoietic anemia.
et al., 1987, 1989, 1990) . Nevertheless, lack of familial genetic data and the presence of normal ␣M-II levels in The human CDAs comprise a heterogenic group of three clinically defined anemias for which the genetic all but one case reported thus far calls into question the role of ␣M-II mutation in most instances of human CDA of the endoplasmic reticulum in some CDA type II erythrocytes (Fukuda, 1993) . Neither was there hepatomegtype II.
Significant differences appear between CDA type II aly, liver cirrhosis, or hemosiderosis. It is possible that these phenotypic variations reflect species-specific glyand mouse ␣M-II deficiency. No evidence for multinucleated erythroblasts could be found in the ␣M-II-deficient cosylation functions, or perhaps the genetic heterogeneity of human CDA type II. Whatever the reasons for mouse bone marrow, although these are commonly found in marrow from CDA type II patients. Moreover, the reported differences, our results indicate that loss of ␣M-II gene function is one genetic basis for congenital electron microscopic analyses did not detect the "double membrane" effect that may reflect incomplete loss dyserythropoietic anemia.
complex N-glycan levels, suggesting that ␣M-III activity age (Jaeken et al., 1994; Tan et al., 1996 ; R. Campbell revealing an alternate pathway in N-glycan biosynthesis, without which erythroid complex N-glycan production fails and dyserythropoietic anemia ensues.
The Alternate Pathway to Complex N-Glycan Production in Normal and

Experimental Procedures
Disease Physiology
The alternate pathway in complex N-glycan biosynthe-
Production of Targeted Embryonic Stem Cell Lines and ␣M-II-Deficient Mice
sis provides a mechanism to compensate for the ab-
The mouse ␣M-II cDNA was used to sence of ␣M-II. Nevertheless, erythroid cells cannot isolate a 17 kb mouse genomic ␣M-II clone from a 129/SvJ library compensate for ␣M-II deficiency, and this appears to (Stratagene) by cross-hybridization as previously described (Priatel, explain the cell-type specificity of the phenotype ob- tively, ␣M-III may be relatively labile, with loss of cofactissue culture dishes as described (Priatel et al., 1997) . PCR positive tors occurring early in erythrocyte maturation and prior clones were analyzed using an ␣M-II genomic probe consisting of a 1.1 kb SmaI-XbaI fragment as denoted (Figure 2A ). The loxP probe to enucleation. Characterization of the gene(s) responsiconsisted of two loxP sites separated by plasmid multiple-cloning ble for encoding ␣M-III activity is needed to address sites (Hennet et al., 1995) . ES cell clones bearing a targeted ␣M-II these issues. In this regard, recent analyses of a human allele were electroporated with 10 g of supercoiled Cre expression gene product termed ␣M-IIx (Misago et al., 1995) have plasmid pCre-Hygro and plated at low dilution. After 4 days, ganrevealed that the encoded ␣M enzyme is located in the ciclovir (2 ϫ 10 6 M) was added, and, 5 days later, resistant subclones were analyzed by Southern blotting. Chimeric mice were produced cis Golgi and acts on Man 5 GlcNAc 2 Ϫ to produce Man 3 Glby microinjection of 8-10 clonal ES cells into 3.5 day C57BL/6 blastocNAc 2 Ϫ (M. N. F., unpublished data). Whether human cyst-stage embryos, followed by implantation as described (Metzler ␣M-IIx is the homolog of the gene encoding ␣M- III activet al., 1994 with different enzymatic properties arising from significant structural divergence.
␣M-II and ␣M-III Enzymatic Analyses
Among nonerythroid cells studied in ␣M-II-deficient
Mouse tissues were homogenized in 1-2 ml of extraction buffer (2% Triton X-100, 0.5 M NaCl, 20 mM potassium phosphate [pH 7.5]), mice, these harbored approximately 50% of normal The ␣M-III designation is a tentative nomenclature based upon the differences in ␣M-I and ␣M-II activities previously defined within the N-glycan processing pathway. The Co 2ϩ -activated ␣M previously described (Bonay and Hughes, 1991; Bonay et al., 1992 ) is a likely candidate for the ␣M-III activity detected herein among Golgi and microsomal fractions, although it is not presently possible to rule out the existence of multiple isozymes.
centrifuged at 16,000 ϫ g for 5 min, and assayed for ␣M activity with were labeled in a final volume of 100 l with either fluorescein (FITC)-pNP-Man and GlcNAc1Man5GlcNAc1-PA substrates as total cellular conjugated E-PHA (1 g/ml) or Jacalin-FITC (0.5 g/ml) (Vector Labsupernatants, or as immunoprecipitates using 2 l anti-Man II antioratories). Subsequently, cells were incubated with 1 l of indicated serum Liao et al., 1996) . Microsomes and antibody for 10 min. All incubations and washes were performed Golgi membranes were prepared as previously described (Moremen on ice in FACS buffer (2% FCS in PBS). Cells were analyzed using and Touster, 1986) and stored at Ϫ20ЊC prior to analyses with a FACScan Flow Cytometer and CellQuest Software (Becton DickinGlcNAc 1Man5GlcNAc-PA and Man5GlcNAc-PA as substrates in 100 son, Mountain View, CA) as previously described (Hennet et al., mM NaAc (pH 5.6) and 100 mM N-acetylglucosamine, or in 100 1995). Lineage-specific antibodies included erythroid phycoerythrin mM NaAc (pH 6.5), 100 mM N-acetylglucosamine, and 1 mM CoCl 2 (PE)-conjugated TER-119, myeloid anti-Ly-6G-PE (Gr-1, RB6-8C5), (Bonay and Hughes, 1991; Liao et al., 1996; Merkle et al., 1997) . In B lymphoid anti-B220-PE (RA3-6B2), and T lymphoid anti-CD3-PE all assays, sensitivity to inhibition by swainsonine was tested using (145-2C11) (Pharmingen). a 10 M final concentration of the alkaloid. GlcNAc1Man5GlcNAc and Man 5GlcNAc were kindly provided by Dr. Jeremy Carver (University of Toronto) and by Dr. Annette Herscovics (McGill Cancer CenAsparagine-Linked Oligosaccharide Characterization ter, Montreal), respectively.
Tail biopsy-derived primary fibroblasts were labeled in 5.5 mM glucose DMEM with 20 Ci/ml [2-3 H]mannose for 24 hr. Preparation of Hematology and Histology 3 H-mannose-labeled oligosaccharides hydrolyzed from precursor Mice were anesthetized with methoxyfluorane, and blood was collipid or from protein by PNGaseF digestion was as described lected from the tail vein into EDTA-coated polypropylene tubes (Bec- (Sampath et al., 1992; Panneerselvam and Freeze, 1996) . Splenoton Dickinson). A CELL-DYN 3500 programmed for normal mouse cytes were labeled with 20 Ci/ml 3 H-glucosamine for 24 hr in 98% parameters was used to assess cellular size, volume, and morpholglucose-deficient medium with 2% normal RPMI 1640 and 10% ogy involving red blood cells, leukocytes, and platelets as described dialyzed fetal calf serum. Glycoproteins were extracted with 0.5% (Priatel et al., 1997) . Parallel blood smears were performed and Triton X-100 in 0.1 M Tris-HCl (pH 6.8) containing 0.1 M NaCl, 0.3 M stained with Wright-Giemsa solution or new methylene blue (for sucrose, 3 mM MgCl 2, 1 mM PMSF, and digested with PNGaseF. reticulocyte counts) for manual analyses. Osmotic fragility measured Released N-linked oligosaccharides were reduced to alditols with percent hemolysis by OD 540 in response to indicated NaCl concentra-1 M NaBH 4 and applied to 1 ϫ 4 cm ConA Sepharose columns tions. Levels of RBC Ii-antigens were defined with antisera preequilibrated in 10 mM Tris-HCl (pH 7.5). Oligosaccharides were viously described (Feizi et al., 1979; Hakomori et al., 1981) . Anti-I eluted sequentially with 10 mM ␣-methyl glucoside, 10 mM ␣-methyl or anti-i antisera was serially diluted with PBS in a round-bottom mannoside, and 0.2 M ␣-methyl mannoside. Radioactivity was microtiter plate. RBCs from wild-type or ␣M-II-null mice were added monitored in 1 ml fractions produced. Oligosaccharide-alditols reto each well and incubated on ice for 4 hr, after which the presence solved by ConA-Sepharose chromatography were desialyated by or absence of hemagglutination was assessed.
mild acid hydrolysis and analyzed by ion suppression amine adsorpHistologic studies were performed on paraffin or frozen tissue tion (ISAA)/HPLC using a Varian MicroPak AX-5 column. Standard sections by methods previously described (Campbell et al., 1995) .
high mannose-type oligosaccharides, M9, M8, M7, M6, M5, and a Staining and lectin reagents included hematoxylin/eosin, Oil red O, biantennary complex type oligosaccharide, NA2 (Gal␤1-4GlcNAc␤1-Sudan black, iron (Perls reaction), and lectins E-PHA, ConA, Jacalin, 2Man␣1-3[Gal␤1-4GlcNAc␤1-2Man␣1-6]Man␤1-4GlcNAc␤1-4Glc and L-PHA (Vector Laboratories).
NAcOH), were purchased from Oxford Glycosystems (Oxford, U. K.). M 3 G 2 (Man␣1-3[Man␣1-6]Man␤1-4GlcNAc␤1-4GlcNAcOH) was Flow Cytometric Analyses prepared from NA2 by exoglycosidase digestion. ConA-SephaSingle cell suspensions were isolated from mice and subjected to rose-and HPLC-separated oligosaccharides were exoglycosidase hypotonic lysis of red blood cells, using ammonium chloride when indicated. Cells were counted using a hemocytometer, and 500,000 treated as described (Merkle and Cummings, 1987) .
RBC Protein, Glycoprotein, and Glycolipid Analyses lysis test; a typical congenital dyserythropoietic anaemia. Br. J. Haematol. 17, 11-26. Erythrocyte membranes were prepared and analyzed by SDS-PAGE as previously described (Fairbanks et al., 1971; Fukuda et al., 1984) . Dorling, P.R., Huxtable, C.R., and Vogel, P. (1978) . Lysosomal storIn other studies, intact erythrocytes were labeled with NaB[ 3 H] 4 to age in swainsona spp. toxicosis: an induced mannosidosis. Neuroincorporate tritium on nonreducing terminal galactose and N-acetylpath. Appl. Neurobiol. 4, 285-295. galactosamine residues in glycoproteins and glycolipids (Fukuda et Dorling, P.R., Huxtable, C.R., and Colgate, S.M. (1980) . Inhibition of al., 1979) prior to SDS-PAGE and autoradiography. For lectin blotlysosomal ␣-mannosidase by swainsonine, an indolizidine alkaloid ting, SDS-PAGE-resolved proteins were transferred onto nitrocelluisolated from Swainsona canescens. Biochem. J. 191, 649-651. lose and incubated in PBS-T (PBS containing 0.05% Elbein, A.D., Solf, R., Dorling, P.R., and Vosbeck, K. (1981) . Swainsupplemented with 3% BSA for 4 hr. Blots were subsequently incusonine: an inhibitor of glycoprotein processing. Proc. Natl. Acad. bated with 2 g/ml biotinylated E-PHA (Vector) for 1 hr at 25ЊC, Sci. USA 78, 7393-7397. washed three times in PBS-T, and incubated with avidin-horseradish Fairbanks, G., Steck, T.L., and Wallach, D.F.H. (1971) . Electrophoperoxidase for 30 min prior to development, using ECL as described retic analysis of the major polypeptides of the human erythrocyte (Amersham). For glycolipid analyses, erythrocyte glycolipids were membrane. Biochemistry 10, 2606-2617. extracted from NaB[ 3
